Sign in / Join Now
ETFs & Funds
Wall Street finally giving $
the attention it deserves. No other biotech has anything close to Omecamtiv and Tirasemtiv in development.
Add a reply...
Latest StockTalks »
people get CYTK breaking news and analysis by email alert.
Get email alerts on CYTK »
Get latest price
From other sites
Origent Data Sciences And Cytokinetics Present Analyses Demonstrating Baseline Data Predict Measures Of Vital Capacity In Patients With ALS
at TheStreet (Wed, 7:30AM)
Cytokinetics Announces Presentations At The International Symposium On ALS/MND
at TheStreet (Fri, 4:00PM)
Cytokinetics Announces Start Of GALACTIC-HF, A Phase 3 Clinical Trial Of Omecamtiv Mecarbil
at TheStreet (Dec 1, 2016)
The Lancet Publishes Results From COSMIC-HF Trial Showing Omecamtiv Mecarbil Significantly Improved Cardiac Function In Patients With Chronic Heart Failure
at TheStreet (Nov 30, 2016)
Cytokinetics To Participate In Upcoming Investor Conferences
at TheStreet (Nov 22, 2016)